SCHEMBL30137565

SCHEMBL30137565

CC(C)(C)OC(=O)Nc1cnc(-c2cccc(Cl)c2Cl)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.44
LCK P06239 2/20 0.41
PTPN11 Q06124 1/20 0.41
CDK9 P50750 1/20 0.40
RORC P51449 1/20 0.39
CNR2 P34972 2/20 0.39
ATR Q13535 1/20 0.39
STIM1 Q13586 1/20 0.38
ORAI1 Q96D31 1/20 0.38
ORAI2 Q96SN7 1/20 0.38
GSK3B P49841 1/20 0.38
DYRK1A Q13627 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
DRD2 P14416 2/20 0.37
PDGFRB P09619 1/20 0.37
FGFR1 P11362 1/20 0.37
SRC P12931 1/20 0.37
PDGFRA P16234 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31054055 0.79 LCK (0.40) NUDT1LCKATRPDGFRBFGFR1
SCHEMBL30137586 0.78 ATR (0.42) NUDT1LCKCNR2ATRPDGFRB
SCHEMBL29008076 0.76 MAPKAPK2 (0.46) LCKCDK9ATRGSK3BDYRK1A
SCHEMBL31053916 0.75 LCK (0.43) LCKPTPN11ATRMAPKAPK2PDGFRB
SCHEMBL6078486 0.75 SMN1; SMN2 (0.41) LCKCDK9RORCATRGSK3B
SCHEMBL28146075 0.72 MEN1 (0.60) LCK
SCHEMBL28967353 0.72 CNR1 (0.41) LCKPTPN11RORCATRMAPKAPK2
SCHEMBL30137525 0.72 CNR1 (0.41) LCKPTPN11RORCATRMAPKAPK2
SCHEMBL18308988 0.71 GSK3B (0.47) LCKCDK9RORCATRGSK3B
SCHEMBL28041 0.71 PTK2 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115611869-B Heterocyclic pyrazine derivative and application thereof in preparation of SHP2 inhibitor 山东大学 2024-08-09 CN disclosed
CN-115611869-A Heterocyclic pyrazine derivative and application thereof in preparation of SHP2 inhibitor 山东大学 2023-01-17 CN disclosed